Vascular-Patch is produced from polyester-urethane and is characterized by an excellent biocompatibility and provides long-term mechanical stability. The elastic material ensures minimum suture hole bleeding and a compliance which is unmatched by any other synthetic patch. The microporous structure allows good tissue incorporation. During a highly sophisticated production process the polyester urethane material is formed into a microporous, micro fibrous patch. Vascular patches are characterised by healing properties, fast formation of a neointima and lack of thrombogenicity.
The vascular patches markets have a developing potential owing to the continuous technological advancement in the healthcare sector and growing geriatric population. The major factors driving the vascular patches market are the increasing population under the risk vascular diseases and rising number of vascular surgeries across the world. However, the prominent factor restraining the growth of the global vascular patches market is the excessive cost associated with the vascular patches and risk of infection associated with the use of patches.
The report analyses the vascular patches market on the basis of material, application, end user and geography.
Based on material, the global vascular patches market is categorised into biologic vascular patches and synthetic vascular patches. The biological vascular patches segment leads the vascular patches segment in terms of revenue and is estimated to grow at a faster pace during the forecast period. The high growth of the biological vascular patches segment is primarily attributed to the advantages offered by biological patches as compared to synthetic patches and low-risk associated with the use of biological vascular patches.
Based on application, the global vascular patches market is segmented into carotid endarterectomy, open repair of abdominal aortic aneurysms, vascular bypass surgery and other applications. The vascular bypass surgery segment accounted for highest revenue generator segment in the global vascular patches market. Vascular patches are mostly used in the vascular surgeries owing to its characteristics including low thrombogenicity and biocompatibility.
By end user the vascular patches market is bifurcated into hospitals & clinics and ambulatory surgical centres. The hospital & clinics end user segment is expected to command the largest share of the vascular patches market in 2017. The availability of infrastructure and increasing number of vascular surgeries primarily attributed to the growth of hospital & clinics segment.
By geography vascular patches market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and Middle East & Africa. North America dominates the global vascular patches market. Moreover, Europe is expected to be the fastest-growing region during the prediction period. Factors such as rising patient population in the US and Canada and increasing awareness among the end users about the use of vascular patches is fuelling the growth of the vascular patches market in North America.
Some of the key participants in the vascular patches market are LeMaitre Vascular, Inc, Baxter, MAQUET Holding B.V. & Co. KG, B. Braun Melsungen AG, W. L. Gore & Associates, Inc, Admedus, CryoLife, Inc, C. R. Bard, Inc, Edwards Lifesciences Corporation, Labcor Laboratórios Ltda, TERUMO CORPORATION, etc. , B. Braun Melsungen AG offers a microporous vascular patch which is highly compliance, leak proof due to the high elasticity of the polymer fibres and has excellent handling properties. Mergers, acquisitions, partnership and new product launches are the prominent strategies used by the key players to reinforce their position in the market and widen their geographical presence.
Why to buy this report: